Jane Street Group, LLC Kiniksa Pharmaceuticals, Ltd. Transaction History

Jane Street Group, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$17.63 - $21.74 $828,380 - $1.02 Million	-46,987 Reduced 78.44%	12,914 $254,000
Q4 2023 Feb 14, 2024	BUY	$14.37 - $19.07 $714,950 - $948,789	49,753 Added 490.27%	59,901 $1.05 Million
Q3 2023 Nov 14, 2023	SELL	$13.62 - $20.2 $221,611 - $328,674	-16,271 Reduced 61.59%	10,148 $176,000
Q2 2023 Aug 14, 2023	BUY	$10.44 - $16.48 $275,814 - $435,385	26,419 New	26,419 $371,000
Q3 2022 Nov 14, 2022	SELL	$9.76 - $13.41 $289,530 - $397,807	-29,665 Reduced 72.6%	11,194 $144,000
Q2 2022 Aug 16, 2022	BUY	$7.6 - $11.41 $137,772 - $206,840	18,128 Added 79.75%	40,859 $396,000
Q1 2022 May 17, 2022	BUY	$9.3 - $12.37 $44,733 - $59,499	4,810 Added 26.84%	22,731 $226,000
Q3 2021 Nov 16, 2021	BUY	$11.39 - $16.23 $204,120 - $290,857	17,921 New	17,921 $204,000
Q4 2020 Feb 17, 2021	SELL	$14.8 - $21.15 $156,865 - $224,168	-10,599 Closed	0 $0
Q3 2020 Nov 17, 2020	BUY	$15.21 - $25.53 $161,210 - $270,592	10,599 New	10,599 $162,000

1.95M

Ticker KNSA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,470,400
Market Cap $751M
Description
Kiniksa Pharmaceuticals, Ltd., a biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical needs worldwide. Its product candidates include ARCALYST, an interleukin-1alpha and interleukin-1beta, for the treatm...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.